Internal Med Medical News about Influenza A Virus, H1N1 Subtype Influenza Vaccines

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Despite Demonstrated Safety, Efficacy of H1N1 Vaccine, Uptake Levels Still Uncertain. Public Health Experts Urge Health Care Workers to Get Immunized
American Family Physician, 09/24/09

Mitchell D – Encouraging news about adult clinical trials involving the novel influenza A (H1N1) vaccine could boost uptake levels, but by how much remains to be seen. Uptake for the new vaccine possibly will be similar to that of seasonal flu vaccine. In other words, relatively low. Seasonal influenza vaccine is recommended for more than 80 percent of the U.S. population, but less than 40 percent of Americans receive the vaccine each year. Preliminary data from the clinical trials indicate that health care workers who are immunized with the new H1N1 vaccine will be taking a big step toward protecting themselves, their patients and their co–workers. The newly licensed H1N1 vaccines induce a robust immune response in most healthy adults just eight to 10 days after a single dose of unadjuvanted vaccine containing 15 micrograms of antigen.

<< Previous
Chronic prostatitis presenting with dysfunctional voiding and...

Next >>
Impairment of endogenous melatonin rhythm is related to the...